The Alliance for Regenerative Medicine (ARM) is pleased to invite you to an event — “European Competitiveness in Advanced Therapies: How do we Fulfill the Potential for the Benefit of Patients?” — that we will co-host with ATMP Sweden on 27 June at the Karolinska Institute in Stockholm.
Organized in partnership with the Swedish Presidency of the EU, the event will be an official satellite event to the Presidency’s (invitation only) Conference on “Life Sciences: the Era of Personalised Medicine.”
The event will focus on the revision of the EU pharmaceuticals legislation and the EU Joint Clinical Assessment of ATMPs and how these policy initiatives will affect Europe’s competitiveness in the cell and gene therapy sector.
Please download the current draft agenda by clicking here. Below are the links to register for either in-person or virtual attendance.
For in-person attendance – CLICK HERE
For virtual attendance registration – CLICK HERE
